You searched for severe copd

News

Evrysdi Use Extended to Infants Younger Than 2 Months With Spinal Muscular Atrophy

May 31, 2022

The approval was based on efficacy and safety data from the phase 2 RAINBOWFISH study, which included presymptomatic infants aged from birth to 6 weeks old with genetically diagnosed SMA.

Clinical Charts

COVID-19 Vaccines

May 23, 2022

Types of COVID-19 vaccines in the US, including those approved by the FDA under Emergency Use Authorization, as well as other investigational products currently in Phase 3 clinical trials.

ATS 2022

Using Electronic Health Records to Predict Mortality Post COPD Hospitalization

May 17, 2022

For COPD, can electronic health record data predict 90-day post hospitalization mortality — and thereby serve as a risk stratification tool?

ATS Virtual Program 2020

Low-Severity COPD: Risk for Exacerbation, Hospitalization, and Death

May 17, 2022

What is the risk of future COPD exacerbations, hospitalizations, and death among patients with COPD who had 1 or 0 exacerbation in the previous 12 months?

News

Quviviq Now Available for Adults With Insomnia

May 3, 2022

Daridorexant is a dual orexin receptor antagonist designed to suppress wake drive by blocking the binding of wake-promoting neuropeptides orexin A and orexin B to its receptors.

News

COVID-19 Linked to Increased Risk for DVT, PE, Bleeding

April 11, 2022

Rate ratios were highest for critical COVID-19, and during first versus second and third pandemic waves in Sweden

News

Cabenuva Approval Expanded to Include Adolescents With HIV

March 30, 2022

The expanded approval was supported by data from studies in the adult population and by data from an interim analysis of the phase 1/2 MOCHA study.

MPR Weekly Dose Podcast

MPR Weekly Dose #110: Interview With Dr Tobias Janowitz

March 18, 2022

Subscribe: Apple Podcasts | Deezer | Spotify | Stitcher In this week’s special episode of The Weekly Dose Podcast we interview Dr Tobias Janowitz, a medical oncologist, assistant professor at the Cold Spring Harbor Laboratories and adjunct professor at the Feinstein Institutes. Dr Janowitz was part of a team that recently conducted a phase 2…

Clinical Charts

Upper Respiratory Disorders: Symptoms Comparison

March 3, 2022

Symptoms comparison of common upper respiratory disorders including the common cold, influenza, pharyngitis, allergic rhinitis, and the novel COVID-19.

News

Risk for Progression to Severe COVID-19 Lower With Nirmatrelvir + Ritonavir

March 2, 2022

Treatment of symptomatic COVID-19 with nirmatrelvir plus ritonavir linked to 89% lower risk for progression vs placebo

Active Filters

Your search for severe copd returned 546 results

Sort Results:

Evrysdi Use Extended to Infants Younger Than 2 Months With Spinal Muscular Atrophy

COVID-19 Vaccines

Using Electronic Health Records to Predict Mortality Post COPD Hospitalization

Low-Severity COPD: Risk for Exacerbation, Hospitalization, and Death

Quviviq Now Available for Adults With Insomnia

COVID-19 Linked to Increased Risk for DVT, PE, Bleeding

Cabenuva Approval Expanded to Include Adolescents With HIV

MPR Weekly Dose #110: Interview With Dr Tobias Janowitz

Upper Respiratory Disorders: Symptoms Comparison

Risk for Progression to Severe COVID-19 Lower With Nirmatrelvir + Ritonavir